Victoria deepens biomedical connection with Israel

The establishment of an Israel liaison officer at Parkville’s Melbourne Biomedical Precinct will support the commercialisation of biomedical research, according to the University of Melbourne.

The liaison officer will collaborate with the whole of Victoria’s biomedical sector, including universities, research institutes and industry.

The announcement is the next step from the Victoria Israel Biomedical Innovation and Commercialisation Exchange program which was established in 2017 when Premier Daniel Andrews visited Israel.

The benefit for the entire biomedical sector, including medical manufacturers, was laid out by University of Melbourne vice-president enterprise, Doron Ben-Meir.

“This commitment will help build a base of joint research activity that will generate industry partnerships, commercialisation opportunities and stimulate the creation of high-value jobs,” said Ben-Meir.

The candidate who will fill this role is still to be determined, however the successful applicant will work between Israeli, Australian and Victorian governments in developing funding opportunities for innovation in the biomedical sector.

Israel’s biomedical sector made headlines in April this year, when scientists and researchers at Tel Aviv University announced that they had been able to 3D print a human heart using a patient’s cells and biological material.

The Victorian government has been seeking to strengthen ties between the state and Israel through the establishment of the Victorian Trade and Investment Office in Tel Aviv. The liaison officer will connect Melbourne industry and research with Israeli innovation, according to Minister for Priority Precincts Gavin Jennings.

“The Government is maintaining Melbourne’s place as a world leader in the biomedical sector and collaborations like this will help ensure our standing for many years to come,” said Jennings.

The appointment will be housed within the Melbourne Biomedical Precinct which already collaborates across sectors with industry and agencies to develop new medical technologies and processes.

“This agreement will further strengthen the work already being done at Parkville’s Melbourne Biomedical Precinct, helping bring the world’s best to Victoria,” said Jennings.